{"article_title": "Immunotherapy Cancer Drug Data Show Promise in Prolonging Lives", "article_keywords": ["significantly", "cancer", "reported", "squibb", "study", "skin", "immunotherapy", "drug", "system", "trial", "prolonging", "promise", "unleash", "lives", "data", "researchers"], "article_url": "http://www.wsj.com/articles/immunotherapy-cancer-drug-data-show-promise-in-prolonging-lives-1401679269", "article_text": "CHICAGO\u2014Drugs designed to unleash the body's own immune system against cancer are significantly prolonging the lives of some people with hard-to-treat forms of the deadly disease.\n\nThe latest evidence: Patients with the skin cancer melanoma who received a combination of two Bristol-Myers Squibb Co. immunotherapies in a clinical trial lived an average of more than three years, researchers reported Monday. In another study, about 70% of...", "article_metadata": {"article.template": "snippet", "article.created": "2014-06-02T11:30:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Drugs designed to unleash the body's own immune system against cancer are significantly prolonging the lives of some people with hard-to-treat forms of the deadly disease.", "title": "New Immunotherapy Drug Data Show Promise in Treating Cancer", "image": {"alt": "Immunotherapy cancer drug data show promise in prolonging lives", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "creator": "@Loftus", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424052702303789904579598963352107666&headline=Immunotherapy%20cancer%20drug%20data%20show%20promise%20in%20prolonging%20lives&weburl=http://www.wsj.com/articles/SB10001424052702303789904579598963352107666"}}, "page.site.product": "WSJ", "keywords": "american society of clinical oncology,asco meeting,cancer drugs,immunotherapies,immunotherapy,immunotherapy data,melanoma drugs,Bristol-Myers Squibb,BMY,Merck,MRK,MRK.XE,Roche Holding,ROG.VX,AstraZeneca,AZN.LN,Louis M. Weiner,Antoni Ribas,Derek Raghavan,Jedd D. Wolchok,Mario Sznol,new products,services,research,development,corporate,industrial news,official trials,tests,cancer,political,general news,cancer research,health,medical conditions,skin cancer,pharmaceuticals,health care,life sciences,drugs,medication", "news_keywords": "american society of clinical oncology,asco meeting,cancer drugs,immunotherapies,immunotherapy,immunotherapy data,melanoma drugs,Bristol-Myers Squibb,BMY,Merck", "article.headline": "Immunotherapy cancer drug data show promise in prolonging lives", "description": "Drugs designed to unleash the body's own immune system against cancer are significantly prolonging the lives of some people with hard-to-treat forms of the deadly disease.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424052702303789904579598963352107666&headline=Immunotherapy%20cancer%20drug%20data%20show%20promise%20in%20prolonging%20lives&weburl=http://www.wsj.com/articles/SB10001424052702303789904579598963352107666", "user.type": "nonsubscriber", "testkeys": "C", "article.page": "Business", "article.emb": "video_emb", "article.summary": "Drugs designed to unleash the body's own immune system against cancer are significantly prolonging the lives of some people with hard-to-treat forms of the deadly disease.", "page.site": "wsj", "page.content.format": "responsive", "article.published": "2014-06-02T11:30:00.000Z", "dj.asn": "i-e963", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 2, "video_count": 1, "word_count": 1090, "publisher": "https://www.facebook.com/wsj"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Drugs designed to unleash the body's own immune system against cancer are significantly prolonging the lives of some people with hard-to-treat forms of the deadly disease.", "title": "New Immunotherapy Drug Data Show Promise in Treating Cancer", "url": "http://www.wsj.com/articles/immunotherapy-cancer-drug-data-show-promise-in-prolonging-lives-1401679269", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Peter Loftus and Ron Winslow", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "New Immunotherapy Drug Data Show Promise in Treating Cancer", "article.type": "Business", "article.id": "SB10001424052702303789904579598963352107666", "user.exp": "default", "article.updated": "2014-06-02T11:30:00.000Z"}, "_id": "\"57477af46914bd0286fd813a\"", "article_summary": "CHICAGO\u2014Drugs designed to unleash the body's own immune system against cancer are significantly prolonging the lives of some people with hard-to-treat forms of the deadly disease.\nThe latest evidence: Patients with the skin cancer melanoma who received a combination of two Bristol-Myers Squibb Co. immunotherapies in a clinical trial lived an average of more than three years, researchers reported Monday.\nIn another study, about 70% of..."}